BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25012216)

  • 1. A neuronal function of the tumor suppressor protein merlin.
    Schulz A; Zoch A; Morrison H
    Acta Neuropathol Commun; 2014 Jul; 2():82. PubMed ID: 25012216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.
    Schulz A; Baader SL; Niwa-Kawakita M; Jung MJ; Bauer R; Garcia C; Zoch A; Schacke S; Hagel C; Mautner VF; Hanemann CO; Dun XP; Parkinson DB; Weis J; Schröder JM; Gutmann DH; Giovannini M; Morrison H
    Nat Neurosci; 2013 Apr; 16(4):426-33. PubMed ID: 23455610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.
    Truong K; Ahmad I; Jason Clark J; Seline A; Bertroche T; Mostaert B; Van Daele DJ; Hansen MR
    Neuroscience; 2018 Mar; 374():205-213. PubMed ID: 29408605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.
    Petrilli A; Bott M; Fernández-Valle C
    Oncotarget; 2013 Dec; 4(12):2354-65. PubMed ID: 24259290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and Use of Merlin-Deficient Human Schwann Cells for a High-Throughput Chemical Genomics Screening Assay.
    Petrilli AM; Fernández-Valle C
    Methods Mol Biol; 2018; 1739():161-173. PubMed ID: 29546707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
    Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.
    Toledo A; Grieger E; Karram K; Morrison H; Baader SL
    PLoS One; 2018; 13(5):e0196726. PubMed ID: 29715273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NF2 haploinsufficiency in NF2-associated polyneuropathy.
    Hanemann CO; Diebold R; Kaufmann D
    Brain Pathol; 2007 Oct; 17(4):371-6. PubMed ID: 17655741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.
    Schulz A; Kyselyova A; Baader SL; Jung MJ; Zoch A; Mautner VF; Hagel C; Morrison H
    Brain; 2014 Feb; 137(Pt 2):420-32. PubMed ID: 24309211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.
    Petrilli A; Copik A; Posadas M; Chang LS; Welling DB; Giovannini M; Fernández-Valle C
    Oncogene; 2014 Jul; 33(27):3571-82. PubMed ID: 23934191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.
    Ahmad I; Fernando A; Gurgel R; Jason Clark J; Xu L; Hansen MR
    Neurobiol Dis; 2015 Oct; 82():114-122. PubMed ID: 26057084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.
    Shimizu T; Seto A; Maita N; Hamada K; Tsukita S; Tsukita S; Hakoshima T
    J Biol Chem; 2002 Mar; 277(12):10332-6. PubMed ID: 11756419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
    Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
    Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
    Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ
    Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdc42 regulates Schwann cell radial sorting and myelin sheath folding through NF2/merlin-dependent and independent signaling.
    Guo L; Moon C; Zheng Y; Ratner N
    Glia; 2013 Nov; 61(11):1906-21. PubMed ID: 24014231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
    Gutmann DH; Hirbe AC; Haipek CA
    Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21-activated kinase links Rac/Cdc42 signaling to merlin.
    Xiao GH; Beeser A; Chernoff J; Testa JR
    J Biol Chem; 2002 Jan; 277(2):883-6. PubMed ID: 11719502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
    Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.